120 related articles for article (PubMed ID: 30979487)
1. Intrasplenic Transplantation of Cytotoxic T-Lymphocyte Associated Protein 4-Fas Ligand--Modified Hepatic Oval Cells for Acute Liver Injury in Rats.
Wan Z; Wang X; Zhang X; Zhang X; Chen H
Transplant Proc; 2019 Apr; 51(3):942-950. PubMed ID: 30979487
[TBL] [Abstract][Full Text] [Related]
2. [Adenovirus-mediated CTLA4-FasL gene transfer induces long-term survival of cardiac allograft in rats].
Jin YZ; Wang GM; Li AL; Xie SS
Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1968-74. PubMed ID: 14703432
[TBL] [Abstract][Full Text] [Related]
3. Intraarticular gene delivery of CTLA4-FasL suppresses experimental arthritis.
Zhang W; Wang F; Wang B; Zhang J; Yu JY
Int Immunol; 2012 Jun; 24(6):379-88. PubMed ID: 22354915
[TBL] [Abstract][Full Text] [Related]
4. [Expression of Fas antigen and Fas ligand in acute liver injury induced by carbon tetrachloride in rat].
Wen T; Ren F; Liu Y; Wu ZM; Zhao JY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 Jul; 18(7):417-20. PubMed ID: 16831245
[TBL] [Abstract][Full Text] [Related]
5. CTLA4-FasL fusion product suppresses proliferation of fibroblast-like synoviocytes and progression of adjuvant-induced arthritis in rats.
Zhang W; Wang B; Wang F; Zhang J; Yu J
Mol Immunol; 2012 Mar; 50(3):150-9. PubMed ID: 22325471
[TBL] [Abstract][Full Text] [Related]
6. Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.
Khamri W; Abeles RD; Hou TZ; Anderson AE; El-Masry A; Triantafyllou E; Bernsmeier C; Larsen FS; Singanayagam A; Kudo N; Possamai LA; Lebosse F; Auzinger G; Bernal W; Willars C; Weston CJ; Lombardi G; Wendon J; Thursz M; Antoniades CG
Gastroenterology; 2017 Jul; 153(1):263-276.e8. PubMed ID: 28363639
[TBL] [Abstract][Full Text] [Related]
7. CTLA4-Fas ligand gene transfer mediated by adenovirus induce long-time survival of murine cardiac allografts.
Feng YG; Jin YZ; Zhang QY; Hao J; Wang GM; Xie SS
Transplant Proc; 2005 Jun; 37(5):2379-81. PubMed ID: 15964420
[TBL] [Abstract][Full Text] [Related]
8. Intrasplenic transplantation of allogeneic hepatocytes modified by BCL-2 gene protects rats from acute liver failure.
Wang J; Li W; Min J; Ou Q; Chen J; Song E
Transplant Proc; 2004 Dec; 36(10):2924-6. PubMed ID: 15686661
[TBL] [Abstract][Full Text] [Related]
9. Prolongation of corneal allograft survival by CTLA4-FasL in a murine model.
Shi W; Chen M; Xie L
Graefes Arch Clin Exp Ophthalmol; 2007 Nov; 245(11):1691-7. PubMed ID: 17541621
[TBL] [Abstract][Full Text] [Related]
10. Toxicology and Pharmacokinetic Studies in Mice and Nonhuman Primates of the Nontoxic, Efficient, Targeted Hexameric FasL: CTLA4-FasL.
Makdasi E; Amsili S; Aronin A; Prigozhina TB; Tzdaka K; Gozlan YM; Ben Gigi-Tamir L; Sagiv JY; Shkedy F; Shani N; Tykocinski ML; Dranitzki Elhalel M
Mol Cancer Ther; 2020 Feb; 19(2):513-524. PubMed ID: 31871267
[TBL] [Abstract][Full Text] [Related]
11. Intrasplenic transplantation of encapsulated hepatocytes decreases mortality and improves liver functions in fulminant hepatic failure from 90% partial hepatectomy in rats.
Aoki T; Jin Z; Nishino N; Kato H; Shimizu Y; Niiya T; Murai N; Enami Y; Mitamura K; Koizumi T; Yasuda D; Izumida Y; Avital I; Umehara Y; Demetriou AA; Rozga J; Kusano M
Transplantation; 2005 Apr; 79(7):783-90. PubMed ID: 15818320
[TBL] [Abstract][Full Text] [Related]
12. In vitro proliferation and differentiation of hepatic oval cells and their potential capacity for intrahepatic transplantation.
Li Z; Chen J; Li L; Ran JH; Liu J; Gao TX; Guo BY; Li XH; Liu ZH; Liu GJ; Gao YC; Zhang XL
Braz J Med Biol Res; 2013 Aug; 46(8):681-8. PubMed ID: 23903688
[TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of bipotent liver progenitor cells from adult mouse.
Li WL; Su J; Yao YC; Tao XR; Yan YB; Yu HY; Wang XM; Li JX; Yang YJ; Lau JT; Hu YP
Stem Cells; 2006 Feb; 24(2):322-32. PubMed ID: 16109753
[TBL] [Abstract][Full Text] [Related]
14. Effects of IL-10- and FasL-overexpressing dendritic cells on liver transplantation tolerance in a heterotopic liver transplantation rat model.
Chen L; Zhang L; Zhu Z; He W; Gao L; Zhang W; Liu J; Huang A
Immunol Cell Biol; 2019 Sep; 97(8):714-725. PubMed ID: 30977930
[TBL] [Abstract][Full Text] [Related]
15. CTLA-4. FasL induces alloantigen-specific hyporesponsiveness.
Elhalel MD; Huang JH; Schmidt W; Rachmilewitz J; Tykocinski ML
J Immunol; 2003 Jun; 170(12):5842-50. PubMed ID: 12794109
[TBL] [Abstract][Full Text] [Related]
16. Fas-Fas ligand (CD95-CD95L) and cytotoxic T lymphocyte antigen-4 engagement mediate T cell unresponsiveness in patients with paracoccidioidomycosis.
Campanelli AP; Martins GA; Souto JT; Pereira MS; Livonesi MC; Martinez R; Silva JS
J Infect Dis; 2003 May; 187(9):1496-505. PubMed ID: 12717632
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor β1 and Fas ligand synergistically enhance immune tolerance in dendritic cells in liver transplantation.
Qiu M; Chen Y; Chen L; Zeng J; Liu J
J Surg Res; 2017 Oct; 218():180-193. PubMed ID: 28985848
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo characteristics of hepatic oval cells modified with human hepatocyte growth factor.
Li Z; Chen J; Li L; Ran JH; Li XH; Liu ZH; Liu GJ; Gao YC; Zhang XL; Sun HD
Cell Mol Biol Lett; 2013 Dec; 18(4):507-21. PubMed ID: 24005538
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral cytolytic T-lymphocyte nonresponsiveness: FasL/Fas-mediated inhibition of CD4(+) and CD8(+) antiviral T cells by viral antigen-positive veto cells.
Rich RF; Green WR
J Virol; 1999 May; 73(5):3826-34. PubMed ID: 10196277
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
